Module Database Search
MODULE DESCRIPTOR | |||
---|---|---|---|
Module Title | |||
Specialised Pharmaceutical Care Provision | |||
Reference | PHM134 | Version | 6 |
Created | August 2021 | SCQF Level | SCQF 11 |
Approved | March 2013 | SCQF Points | 30 |
Amended | August 2021 | ECTS Points | 15 |
Aims of Module | |||
---|---|---|---|
To consolidate professional competence in pharmaceutical care through the integration of science with the application of a systematic approach to the management of individual patients with specialised pharmaceutical care needs. |
Learning Outcomes for Module | |
---|---|
On completion of this module, students are expected to be able to: | |
1 | Integrate understanding of pathophysiology, pharmacology, therapeutics, drug delivery and numeric data into pharmaceutical care plans for patients with specialised pharmaceutical care needs. |
2 | Synthesise, document, justify and implement evidence based care plans for individual patients with multiple complex problems and specialised pharmaceutical care needs. |
3 | Critically evaluate information to inform the rational selection of medicines for individual patients with specialised pharmaceutical care needs. |
Indicative Module Content |
---|
Consolidation of the systematic approach to pharmaceutical care practice applied in PHM131. Continued integration of the themes, The Patient, The Medicine and The Pharmacist in the context of delivery of pharmaceutical care to individual patients with specialised needs. Topics include: current issues concerning the medical management of disease states in patient groups with specialised needs such as health-acquired infections, mental health, care of the elderly, stroke, palliative care, pain management, neurology, paediatrics; aspects of clinical pharmacology and therapeutics including application of knowledge and understanding of physiology, pathology, pharmacology and therapeutics to the care of patients with special needs including interpretation of a variety of types of numerical data, including biochemical, haematological, and pharmacokinetic parameters; application of systems of medicines review such as the Chronic Medication Service. |
Module Delivery |
---|
Lectures, coursework sessions (mainly in the form of tutorial sessions) and directed study learning activities including online discussions. |
Indicative Student Workload | Full Time | Part Time |
---|---|---|
Contact Hours | 63 | N/A |
Non-Contact Hours | 237 | N/A |
Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
TOTAL | 300 | N/A |
Actual Placement hours for professional, statutory or regulatory body |   |   |
ASSESSMENT PLAN | |||||
---|---|---|---|---|---|
If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
Component 1 | |||||
Type: | Examination | Weighting: | 100% | Outcomes Assessed: | 1, 2, 3 |
Description: | This is a 1.5 hour written examination. |
MODULE PERFORMANCE DESCRIPTOR | |
---|---|
Explanatory Text | |
Component 1 (EX1) comprises 100% of the module grade. A minimum of a Grade D or better is required to pass the module. | |
Module Grade | Minimum Requirements to achieve Module Grade: |
A | A: a score of 70% or above is required |
B | B: a score of between 60-69% is required |
C | C: a score of between 50-59% is required |
D | D: a score of between 40-49% is required |
E | E: a score of between 35-39% is required |
F | F: a score of less than 35% |
NS | Non-submission of work by published deadline or non-attendance for examination |
Module Requirements | |
---|---|
Prerequisites for Module | Successful completion of MPharm Stage 3. |
Corequisites for module | None. |
Precluded Modules | None. |
INDICATIVE BIBLIOGRAPHY | |
---|---|
1 | BRITISH MEDICAL ASSOCIATION and ROYAL PHARMACEUTICAL SOCIETY. British National Formulary. Current edition. London: BMJ Group and Pharmaceutical Press. |
2 | BRITISH MEDICAL ASSOCIATION. Clinical Evidence. Current edition. London: BMJ Publications. |
3 | COLLEDGE, N.R., WALKER, B.R, RALSTON, S.H. (eds). Davidson's Principles and Practice of Medicine. Current edition. Edinburgh: Churchill Livingstone. |
4 | Other online evidence based therapeutic resources as stipulated during module delivery. |